345 related articles for article (PubMed ID: 18413567)
1. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567
[TBL] [Abstract][Full Text] [Related]
2. Total cholesterol and the risk of Parkinson disease.
Hu G; Antikainen R; Jousilahti P; Kivipelto M; Tuomilehto J
Neurology; 2008 May; 70(21):1972-9. PubMed ID: 18401018
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and the risk of Parkinson disease.
Hu G; Jousilahti P; Nissinen A; Antikainen R; Kivipelto M; Tuomilehto J
Neurology; 2006 Dec; 67(11):1955-9. PubMed ID: 17159100
[TBL] [Abstract][Full Text] [Related]
4. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
Tanasescu M; Leitzmann MF; Rimm EB; Hu FB
Circulation; 2003 May; 107(19):2435-9. PubMed ID: 12719277
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study.
de Lau LM; Schipper CM; Hofman A; Koudstaal PJ; Breteler MM
Arch Neurol; 2005 Aug; 62(8):1265-9. PubMed ID: 16087767
[TBL] [Abstract][Full Text] [Related]
6. Smoking and cognitive function in Parkinson's disease.
Weisskopf MG; Grodstein F; Ascherio A
Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
[TBL] [Abstract][Full Text] [Related]
7. Education and occupations preceding Parkinson disease: a population-based case-control study.
Frigerio R; Elbaz A; Sanft KR; Peterson BJ; Bower JH; Ahlskog JE; Grossardt BR; de Andrade M; Maraganore DM; Rocca WA
Neurology; 2005 Nov; 65(10):1575-83. PubMed ID: 16301484
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
9. Diabetes preceding Parkinson's disease onset. A case-control study.
D'Amelio M; Ragonese P; Callari G; Di Benedetto N; Palmeri B; Terruso V; Salemi G; Famoso G; Aridon P; Savettieri G
Parkinsonism Relat Disord; 2009 Nov; 15(9):660-4. PubMed ID: 19356970
[TBL] [Abstract][Full Text] [Related]
10. New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study.
Smith NL; Barzilay JI; Kronmal R; Lumley T; Enquobahrie D; Psaty BM
Diabetes Care; 2006 Sep; 29(9):2012-7. PubMed ID: 16936145
[TBL] [Abstract][Full Text] [Related]
11. Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients.
Söderqvist A; Ekström W; Ponzer S; Pettersson H; Cederholm T; Dalén N; Hedström M; Tidermark J;
Gerontology; 2009; 55(5):496-504. PubMed ID: 19628932
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
13. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
14. Burden of illness score for elderly persons: risk adjustment incorporating the cumulative impact of diseases, physiologic abnormalities, and functional impairments.
Inouye SK; Bogardus ST; Vitagliano G; Desai MM; Williams CS; Grady JN; Scinto JD
Med Care; 2003 Jan; 41(1):70-83. PubMed ID: 12544545
[TBL] [Abstract][Full Text] [Related]
15. Topical beta-blockers and mortality.
Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of mortality predictors in Parkinson's disease in Nigerians.
Okubadejo NU; Ojini FI; Danesi MA
Afr J Med Med Sci; 2005 Dec; 34(4):365-9. PubMed ID: 16752667
[TBL] [Abstract][Full Text] [Related]
17. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
Marras C; McDermott MP; Rochon PA; Tanner CM; Naglie G; Rudolph A; Lang AE;
Neurology; 2005 Jan; 64(1):87-93. PubMed ID: 15642909
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study.
Rose KM; Eigenbrodt ML; Biga RL; Couper DJ; Light KC; Sharrett AR; Heiss G
Circulation; 2006 Aug; 114(7):630-6. PubMed ID: 16894039
[TBL] [Abstract][Full Text] [Related]
19. The mortality risks of smokers in Taiwan: Part I: cause-specific mortality.
Wen CP; Tsai SP; Chen CJ; Cheng TY
Prev Med; 2004 Sep; 39(3):528-35. PubMed ID: 15313092
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
